Description: Lux Health Tech Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Home Page: www.luxcapital.com/companies/lux-health-te
LUXA Technical Analysis
920 Broadway
New York,
NY
10010
United States
Phone:
646 475 4385
Officers
Name | Title |
---|---|
Mr. Joshua Defonzo | CEO & Director |
Ms. Segolene Scarborough | CFO & Treasurer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 21.8478 |
Price-to-Book MRQ: | 1.3129 |
Price-to-Sales TTM: | 0 |
IPO Date: | 2020-12-18 |
Fiscal Year End: | December |
Full Time Employees: | 0 |